全文获取类型
收费全文 | 840篇 |
免费 | 28篇 |
国内免费 | 9篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 50篇 |
妇产科学 | 13篇 |
基础医学 | 81篇 |
口腔科学 | 12篇 |
临床医学 | 79篇 |
内科学 | 172篇 |
皮肤病学 | 11篇 |
神经病学 | 79篇 |
特种医学 | 138篇 |
外科学 | 64篇 |
综合类 | 18篇 |
预防医学 | 62篇 |
眼科学 | 2篇 |
药学 | 47篇 |
1篇 | |
中国医学 | 6篇 |
肿瘤学 | 40篇 |
出版年
2022年 | 8篇 |
2021年 | 6篇 |
2019年 | 5篇 |
2018年 | 8篇 |
2017年 | 6篇 |
2016年 | 6篇 |
2015年 | 7篇 |
2014年 | 19篇 |
2013年 | 20篇 |
2012年 | 21篇 |
2011年 | 31篇 |
2010年 | 33篇 |
2009年 | 28篇 |
2008年 | 33篇 |
2007年 | 40篇 |
2006年 | 36篇 |
2005年 | 21篇 |
2004年 | 14篇 |
2003年 | 20篇 |
2002年 | 13篇 |
2001年 | 21篇 |
2000年 | 16篇 |
1999年 | 14篇 |
1998年 | 29篇 |
1997年 | 31篇 |
1996年 | 45篇 |
1995年 | 37篇 |
1994年 | 35篇 |
1993年 | 18篇 |
1992年 | 12篇 |
1991年 | 16篇 |
1990年 | 16篇 |
1989年 | 30篇 |
1988年 | 30篇 |
1987年 | 21篇 |
1986年 | 17篇 |
1985年 | 17篇 |
1984年 | 11篇 |
1983年 | 7篇 |
1982年 | 7篇 |
1981年 | 8篇 |
1980年 | 10篇 |
1979年 | 5篇 |
1978年 | 5篇 |
1977年 | 10篇 |
1976年 | 5篇 |
1975年 | 6篇 |
1974年 | 3篇 |
1973年 | 6篇 |
1965年 | 3篇 |
排序方式: 共有877条查询结果,搜索用时 31 毫秒
871.
Stroup SP Altamar HO L'Esperance JO Auge BK 《Journal of endourology / Endourological Society》2007,21(7):735-737
Renal-cell carcinoma (RCC) is rarely reported during pregnancy. Both the open and the laparoscopic approach to nephrectomy have been used effectively and safely in pregnant patients with RCC. We report a unique case of a 52-year-old woman found to have RCC during twin gestation who was treated with retroperitoneoscopic radical nephrectomy, one of the first such cases managed by this approach. 相似文献
872.
SE Lamb J Pepper R Lall EC J?rstad-Stein MD Clark L Hill J Fereday-Smith 《BMC women's health》2009,9(1):26
Background
The aim was to compare effectiveness of group versus individual sessions of physiotherapy in terms of symptoms, quality of life, and costs, and to investigate the effect of patient preference on uptake and outcome of treatment. 相似文献873.
T. Scott Stroup Jeffrey A. Lieberman Joseph P. McEvoy Sonia M. Davis Marvin S. Swartz Richard S.E. Keefe Alexander L. Miller Robert A. Rosenheck John K. Hsiao 《Schizophrenia Research》2009,107(1):1-12
ObjectiveThe Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study examined the comparative effectiveness of antipsychotic treatments for individuals with chronic schizophrenia. Patients who had discontinued antipsychotic treatment in phases 1 and 2 were eligible for phase 3, in which they selected one of nine antipsychotic regimens with the help of their study doctor. We describe the characteristics of the patients who selected each treatment option and their outcomes.MethodTwo hundred and seventy patients entered phase 3. The open-label treatment options were monotherapy with oral aripiprazole, clozapine, olanzapine, perphenazine, quetiapine, risperidone, ziprasidone, long-acting injectable fluphenazine decanoate, or a combination of any two of these treatments.ResultsFew patients selected fluphenazine decanoate (n = 9) or perphenazine (n = 4). Similar numbers selected each of the other options (range 33–41). Of the seven common choices, those who selected clozapine and combination antipsychotic treatment were the most symptomatic, and those who selected aripiprazole and ziprasidone had the highest body mass index. Symptoms improved for all groups, although the improvements were modest for the groups starting with relatively mild levels of symptoms. Side effect profiles of the medications varied considerably but medication discontinuations due to intolerability were rare (7% overall).ConclusionsPatients and their doctors made treatment selections based on clinical factors, including severity of symptoms, response to prior treatments, and physical health status. Fluphenazine decanoate was rarely used among those with evidence of treatment non-adherence and clozapine was underutilized for those with poor previous response. Combination antipsychotic treatment warrants further study. 相似文献
874.
875.
876.
877.
BACKGROUND: Quantitative ultrasound (QUS) devices provide portable, easy-to-operate, low-cost options for point-of-care screening of bone mineral density (BMD). Community pharmacists should be aware of the precision, sensitivity, and specificity of these devices prior to their purchase. OBJECTIVE: To determine the precision, sensitivity, and specificity of the Achilles Express ultrasonometer compared with central dual-energy X-ray absorptiometry (cDXA) as well as its utility as a bone density screening device in the community pharmacy setting. METHODS: A prospective study in a community pharmacy and outpatient ambulatory clinic was conducted with 2 groups of white women. Group 1 participants were 25-35 years of age (young, healthy), and those in Group 2 were 45 years of age or older (postmenopausal). BMD assessments of the spine and the nondominant wrist and hip were performed using cDXA. Assessments of the heel were performed using the Achilles Express, a QUS device. The main outcome measures were correlation of t-scores between cDXA and QUS measurements using the Pearson correlation test. RESULTS: Twenty-two (30 +/- 4 years of age) and 31 (55 +/- 17 years of age) women were enrolled into Groups 1 and 2, respectively. Significant correlations between QUS and hip and spine cDXA t-scores were found in both groups. Correlation coefficients for QUS versus hip cDXA were 0.51 (95% CI 0.11 to 0.77) and 0.70 (95% CI 0.46 to 0.85) in Groups 1 and 2, respectively. Correlation coefficients for the QUS versus spine cDXA were 0.64 (95% CI 0.31 to 0.84) and 0.60 (95% CI 0.31 to 0.79) in Groups 1 and 2, respectively. The QUS device has a sensitivity level of 88% and specificity of 71% to detect a hip cDXA t-score of less than-1. CONCLUSIONS: The Achilles Express ultrasonometer is a reasonable screening tool to detect low BMD in postmenopausal women. 相似文献